Search research articles
Contact Us
Filters
Showing results (51-60 of 110) with videos related to
Page
of 11
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
October 6, 2009
CD94 defines phenotypically and functionally distinct mouse NK cell subsets
Jianhua Yu, Min Wei, Hsiaoyin Mao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 9, 2014
A phase I trial of single-agent reolysin in patients with relapsed multiple myeloma
Douglas W Sborov, Gerard J Nuovo, Andrew Stiff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2012
Phase I trial of anti-CS1 monoclonal antibody elotuzumab in combination with bortezomib in the treatment of relapsed/refractory multiple myeloma
Andrzej J Jakubowiak, Don M Benson, William Bensinger, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 14, 2019
Lenalidomide and Vorinostat Maintenance after Autologous Transplantation in Multiple Myeloma: Long- Term Follow-Up
Nidhi Sharma, David T Chen, Qiuhong Zhao, et al.
Leukemia & Lymphoma
|
August 29, 2014
Lower dose of antithymocyte globulin does not increase graft-versus-host disease in patients undergoing reduced-intensity conditioning allogeneic hematopoietic stem cell transplant
Galena Salem, Amy S Ruppert, Patrick Elder, et al.
Nature Immunology
|
December 13, 2018
The IL-15-AKT-XBP1s signaling pathway contributes to effector functions and survival in human NK cells
Yufeng Wang, Yibo Zhang, Ping Yi, et al.
Cancer Immunology Research
|
May 18, 2018
A CS1-NKG2D Bispecific Antibody Collectively Activates Cytolytic Immune Cells against Multiple Myeloma
Wing Keung Chan, Siwen Kang, Youssef Youssef, et al.
Proteomics
|
August 29, 2013
Characterization of multiple myeloma vesicles by label-free relative quantitation
Sean W Harshman, Alessandro Canella, Paul D Ciarlariello, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 25, 2019
T Cell Transcriptional Profiling and Immunophenotyping Uncover LAG3 as a Potential Significant Target of Immune Modulation in Multiple Myeloma
Fabienne Lucas, Michael Pennell, Ying Huang, et al.
Leukemia & Lymphoma
|
February 16, 2019
Tocilizumab as first-line therapy for steroid-refractory acute graft-versus-host-disease: analysis of a single-center experience
Filiz Yucebay, Christina Matthews, Marcin Puto, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 110) with videos related to
Sort By:
Page
of 11
Journal of Immunology (Baltimore, Md. : 1950)
|
October 6, 2009
CD94 defines phenotypically and functionally distinct mouse NK cell subsets
Jianhua Yu, Min Wei, Hsiaoyin Mao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 9, 2014
A phase I trial of single-agent reolysin in patients with relapsed multiple myeloma
Douglas W Sborov, Gerard J Nuovo, Andrew Stiff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2012
Phase I trial of anti-CS1 monoclonal antibody elotuzumab in combination with bortezomib in the treatment of relapsed/refractory multiple myeloma
Andrzej J Jakubowiak, Don M Benson, William Bensinger, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 14, 2019
Lenalidomide and Vorinostat Maintenance after Autologous Transplantation in Multiple Myeloma: Long- Term Follow-Up
Nidhi Sharma, David T Chen, Qiuhong Zhao, et al.
Leukemia & Lymphoma
|
August 29, 2014
Lower dose of antithymocyte globulin does not increase graft-versus-host disease in patients undergoing reduced-intensity conditioning allogeneic hematopoietic stem cell transplant
Galena Salem, Amy S Ruppert, Patrick Elder, et al.
Nature Immunology
|
December 13, 2018
The IL-15-AKT-XBP1s signaling pathway contributes to effector functions and survival in human NK cells
Yufeng Wang, Yibo Zhang, Ping Yi, et al.
Cancer Immunology Research
|
May 18, 2018
A CS1-NKG2D Bispecific Antibody Collectively Activates Cytolytic Immune Cells against Multiple Myeloma
Wing Keung Chan, Siwen Kang, Youssef Youssef, et al.
Proteomics
|
August 29, 2013
Characterization of multiple myeloma vesicles by label-free relative quantitation
Sean W Harshman, Alessandro Canella, Paul D Ciarlariello, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 25, 2019
T Cell Transcriptional Profiling and Immunophenotyping Uncover LAG3 as a Potential Significant Target of Immune Modulation in Multiple Myeloma
Fabienne Lucas, Michael Pennell, Ying Huang, et al.
Leukemia & Lymphoma
|
February 16, 2019
Tocilizumab as first-line therapy for steroid-refractory acute graft-versus-host-disease: analysis of a single-center experience
Filiz Yucebay, Christina Matthews, Marcin Puto, et al.
Page
of 11